Michael Zdanowski

Insider Reports History

Entity
Individual
Location
C/O Talaris Therapeutics, Inc., 93 Worcester Street, Suite 120, Wellesley, MA
Signature
/s/ Mary Kay Fenton, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Zdanowski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. Chief Technology Officer Stock Appreciation Right 150K Feb 1, 2023 Direct
Talaris Therapeutics, Inc. Chief Technology Officer Stock Option (Right to Buy) 150K Feb 1, 2023 Direct

Insider Reports Filed by Michael Zdanowski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TALS Talaris Therapeutics, Inc. Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Technology Officer
TALS Talaris Therapeutics, Inc. Sep 10, 2022 1 $0 4 Sep 13, 2022 Chief Technology Officer
TALS Talaris Therapeutics, Inc. Feb 1, 2022 2 $19.1K 4 Feb 2, 2022 Chief Technology Officer